2006

Go to navigation
Go to content

Pages
1
2
Next

- 07 December 2007
- AstraZeneca Won China Staff Human Resources Awards
- 22 November 2007
- AstraZeneca signs distribution agreement with Par Pharmaceutical for an authorized generic version of TOPROL-XL
- 09 October 2007
- AstraZeneca Successfully Completes Mutual Recognition Procedure For Symbicort Maintenance And Reliever Therapy (Symbicort SMART) in the EU
- 15 September 2007
- AstraZeneca and Schering AG form strategic alliance to develop novel SERD breast cancer drug
- 22 August 2007
- AstraZeneca and Pozen to co-develop and commercialize Treatment for Chronic Pain
- 08 June 2007
- AstraZeneca Outlines Strategy to Further Strengthen Its Product Pipeline While Delivering Continued Sales and Earnings Growth
- 05 December 2006
- AstraZeneca Commitment To China Recognised by Cathay Pacific Award
- 04 December 2006
- AstraZeneca Licenses Rights for the Development and Commercialisation of CUBICIN® in China
- 20 October 2006
- One Single Medication Can Treat Bipolar Disorder Now
- 22 July 2006
- ASTRAZENECA'S SYMBICORT® (BUDESONIDE/FORMOTEROL) TREATMENT FOR ASTHMA APPROVED BY THE FDA

Pages
1
2
Next

Quick links

Page tools

中文版

www.astrazeneca.com.cn

Information contained in this site is solely intended for the use of residents of mainland China.